Background: Biologics are the cornerstone of therapy in children and adolescents with severe or uncontrolled allergic diseases, such as asthma, atopic dermatitis, and chronic urticaria. Since the World Health Organization (WHO) declared severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection a pandemic in March 2020, some scientific societies have released statements on the use of biologics in allergic children and adolescents.

中文翻译：

---

COVID-19 大流行期间过敏和哮喘儿童和青少年的生物制品使用

背景：生物制剂是治疗患有严重或无法控制的过敏性疾病（如哮喘、特应性皮炎和慢性荨麻疹）的儿童和青少年的基石。自世界卫生组织 (WHO) 于 2020 年 3 月宣布严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 感染为大流行病以来，一些科学学会已经发布了关于在过敏性儿童和青少年中使用生物制剂的声明。